Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets

IF 10.7 Q1 MEDICINE, RESEARCH & EXPERIMENTAL MedComm Pub Date : 2024-11-28 DOI:10.1002/mco2.70024
Shen'er Qian, Yao Long, Guolin Tan, Xiaoguang Li, Bo Xiang, Yongguang Tao, Zuozhong Xie, Xiaowei Zhang
{"title":"Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets","authors":"Shen'er Qian,&nbsp;Yao Long,&nbsp;Guolin Tan,&nbsp;Xiaoguang Li,&nbsp;Bo Xiang,&nbsp;Yongguang Tao,&nbsp;Zuozhong Xie,&nbsp;Xiaowei Zhang","doi":"10.1002/mco2.70024","DOIUrl":null,"url":null,"abstract":"<p>Programmed cell death represents a precisely regulated and active cellular demise, governed by a complex network of specific genes and proteins. The identification of multiple forms of programmed cell death has significantly advanced the understanding of its intricate mechanisms, as demonstrated in recent studies. A thorough grasp of these processes is essential across various biological disciplines and in the study of diseases. Nonetheless, despite notable progress, the exploration of the relationship between programmed cell death and disease, as well as its clinical application, are still in a nascent stage. Therefore, further exploration of programmed cell death and the development of corresponding therapeutic methods and strategies holds substantial potential. Our review provides a detailed examination of the primary mechanisms behind apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis. Following this, the discussion delves into biological functions and diseases associated dysregulated programmed cell death. Finally, we highlight existing and potential therapeutic targets and strategies focused on cancers and neurodegenerative diseases. This review aims to summarize the latest insights on programmed cell death from mechanisms to diseases and provides a more reliable approach for clinical transformation.</p>","PeriodicalId":94133,"journal":{"name":"MedComm","volume":"5 12","pages":""},"PeriodicalIF":10.7000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mco2.70024","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedComm","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mco2.70024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Programmed cell death represents a precisely regulated and active cellular demise, governed by a complex network of specific genes and proteins. The identification of multiple forms of programmed cell death has significantly advanced the understanding of its intricate mechanisms, as demonstrated in recent studies. A thorough grasp of these processes is essential across various biological disciplines and in the study of diseases. Nonetheless, despite notable progress, the exploration of the relationship between programmed cell death and disease, as well as its clinical application, are still in a nascent stage. Therefore, further exploration of programmed cell death and the development of corresponding therapeutic methods and strategies holds substantial potential. Our review provides a detailed examination of the primary mechanisms behind apoptosis, autophagy, necroptosis, pyroptosis, and ferroptosis. Following this, the discussion delves into biological functions and diseases associated dysregulated programmed cell death. Finally, we highlight existing and potential therapeutic targets and strategies focused on cancers and neurodegenerative diseases. This review aims to summarize the latest insights on programmed cell death from mechanisms to diseases and provides a more reliable approach for clinical transformation.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
程序性细胞死亡:分子机制、生物学功能、疾病和治疗靶点
程序性细胞死亡是一种由特定基因和蛋白质组成的复杂网络精确调控和活跃的细胞死亡。最近的研究表明,对多种形式的程序性细胞死亡的识别大大提高了对其复杂机制的理解。在各种生物学科和疾病研究中,对这些过程的全面掌握是必不可少的。然而,尽管取得了显著进展,但对程序性细胞死亡与疾病之间关系的探索及其临床应用仍处于初级阶段。因此,进一步探索程序性细胞死亡以及相应的治疗方法和策略具有巨大的潜力。我们的综述提供了细胞凋亡、自噬、坏死坏死、焦亡和铁亡背后的主要机制的详细研究。在此之后,讨论深入到与失调的程序性细胞死亡相关的生物功能和疾病。最后,我们强调了癌症和神经退行性疾病的现有和潜在的治疗靶点和策略。本文旨在总结程序性细胞死亡从机制到疾病的最新见解,为临床转化提供更可靠的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.70
自引率
0.00%
发文量
0
审稿时长
10 weeks
期刊最新文献
Cerebral Venous Outflow Insufficiency: A Study on Symptoms and Venous Stenosis Classification. Cerebrospinal Fluid Genetics Enhance Risk Stratification in Bipolar Disorder. Clinical, Prognostic, and Biological Features of High-Risk Cardiometabolic Phenotype: The REMODEL Study. Immune Exhaustion in Chronic Infection and Cancer: Signaling Pathways and Therapeutic Interventions. RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1